165 results
6-K
TAK
Takeda Pharmaceutical Co
7 Jun 24
Current report (foreign)
6:07am
, and with a late-stage pipeline with the potential to deliver significant value. The company must balance the need to invest in this innovative pipeline
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
29 May 24
Current report (foreign)
6:29am
: Approvals, Pivotal Study Start, and other key events1 40% Reflects future strength of Takeda’s overall performance through delivery of innovative
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
29 May 24
Current report (foreign)
6:29am
of sight back to growth after this period of generic exposure, thanks to our portfolio of Growth & Launch Products and our innovative pipeline … drug listing, supports our aspiration to give Chinese patients access to our most innovative medicines as quickly as possible. Our China Business Unit
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
29 May 24
Current report (foreign)
6:24am
transformation and advancing measures to build the Company’s R&D pipeline, including driving innovative R&D agendas that leverage the Company’s expertise … in PDT and Vaccines. We focus on developing innovative medicines that make a difference in people’s lives by advancing the frontier of new treatment
6-K
TAK
Takeda Pharmaceutical Co
9 May 24
Current report (foreign)
6:03am
through continued advancement of Takeda’s Growth & Launch Products and progressing the company’s robust late-stage pipeline to deliver innovative
6-K
si48 gvezax
9 May 24
Current report (foreign)
6:01am
6-K
p51hq4qwhavs
2 Feb 24
Current report (foreign)
6:16am
6-K
EX-99.1
tfgbule
30 Nov 23
Current report (foreign)
6:01am
6-K
xhg56ki96
13 Nov 23
Current report (foreign)
6:05am
6-K
j9yjfdlxhmth52qg7ws
30 Oct 23
Current report (foreign)
6:02am
6-K
l753na2gl 6x2
1 Aug 23
Current report (foreign)
6:10am
6-K
EX-99.1
ep85wxz3mczke1l
6 Jul 23
Current report (foreign)
6:18am
6-K
EX-99.1
qu0okc7
23 Jun 23
Current report (foreign)
6:13am
6-K
u3trl9qlw 8pagc
30 May 23
Current report (foreign)
6:20am
6-K
EX-99.1
c4xsti 29m1w
30 May 23
Current report (foreign)
6:19am
6-K
EX-99.1
3j2nxvv7tg8r 7zqacs0
30 May 23
Current report (foreign)
6:11am
6-K
ql15k9jg d7hq
11 May 23
Current report (foreign)
6:07am
6-K
3eeg6oxuxd
30 Mar 23
Current report (foreign)
6:19am
6-K
EX-99.1
rg1xjym 32c5gyqsk
21 Dec 22
Current report (foreign)
6:01am